Page last updated: 2024-10-27

furosemide and Coronavirus Infections

furosemide has been researched along with Coronavirus Infections in 1 studies

Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.

Coronavirus Infections: Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).

Research Excerpts

ExcerptRelevanceReference
"Furosemide is a "repurpose-able" small molecule therapeutics, that is safe, easily synthesized, handled, and stored, and is available in reasonable quantities worldwide."2.66Is Inhaled Furosemide a Potential Therapeutic for COVID-19? ( Barden, C; Brennecke, A; Doyle, LM; Meek, A; Reed, M; Villar, L; Wang, Z; Weaver, DF, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brennecke, A1
Villar, L1
Wang, Z1
Doyle, LM1
Meek, A1
Reed, M1
Barden, C1
Weaver, DF1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19 - A Phase 2/3 Study[NCT04588792]Phase 2/Phase 340 participants (Actual)Interventional2021-04-16Terminated (stopped due to Lack of recruitment due to decline in critically ill Covid-19 patients)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for furosemide and Coronavirus Infections

ArticleYear
Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
    The American journal of the medical sciences, 2020, Volume: 360, Issue:3

    Topics: Administration, Inhalation; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Fur

2020